Arxada (CDMO)
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Arxada (CDMO) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Switzerland
Founded:2007
Employees:1,737
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Manufacturing Facilities
1 site worldwide
ARCH CHEMICALS, INC.
100 Mckee Rd, Rochester, New York, 14611-2013
Site Capabilities
1 capabilityAPI MANUFACTURE
Regulatory Approvals
Drug Approval OAVH89
FDA · #APR-GZ4AN39L · 2022-01-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-47UF5EYX
Issued: 2020-07-25
Expires: 2025-01-18
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-O4EUZ4IB
Issued: 2020-10-14
Expires: 2025-11-01
Loading CDMO intelligence...
Key facts about Arxada (CDMO)
- Arxada (CDMO) is headquartered in Switzerland.
- Arxada (CDMO) was founded in 2007.
- Arxada (CDMO) has 1,737 employees.
- Arxada (CDMO) has one manufacturing site listed on CDMO Hub, in Rochester, United States.
- Arxada (CDMO)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Arxada (CDMO)
Directory pages this company appears in, each with the full list of matching manufacturers.